Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
1.400
+0.090 (6.87%)
May 13, 2025, 4:00 PM - Market closed
Tango Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 58.43 | 69.53 | 66.39 | 59.97 | 142.75 | 28.38 | Upgrade
|
| Short-Term Investments | 158.29 | 188.39 | 270.5 | 306.17 | 342.51 | 161.94 | Upgrade
|
| Cash & Short-Term Investments | 216.72 | 257.92 | 336.89 | 366.13 | 485.26 | 190.32 | Upgrade
|
| Cash Growth | -36.93% | -23.44% | -7.99% | -24.55% | 154.97% | 370.80% | Upgrade
|
| Receivables | - | - | - | 2 | 2 | 2 | Upgrade
|
| Prepaid Expenses | 7.78 | 8.43 | 8.8 | 6.57 | 4.52 | 1.31 | Upgrade
|
| Restricted Cash | 0.43 | - | 0.86 | 0.57 | 0.57 | - | Upgrade
|
| Total Current Assets | 224.93 | 266.34 | 346.54 | 375.27 | 492.34 | 193.63 | Upgrade
|
| Property, Plant & Equipment | 47.24 | 47.58 | 53.42 | 57.77 | 6.09 | 11.3 | Upgrade
|
| Other Long-Term Assets | 2.14 | 2.57 | 2.61 | 3.43 | 1.73 | 2.32 | Upgrade
|
| Total Assets | 274.31 | 316.49 | 402.57 | 436.47 | 500.16 | 207.25 | Upgrade
|
| Accounts Payable | 3.24 | 1.6 | 2.79 | 4.45 | 3.23 | 1.84 | Upgrade
|
| Accrued Expenses | 8.4 | 14.76 | 14.11 | 16.23 | 9.22 | 5.35 | Upgrade
|
| Current Portion of Leases | 2.82 | 2.45 | 2.08 | 1.77 | 1.5 | 0.96 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.04 | 0.05 | - | Upgrade
|
| Current Unearned Revenue | 19.48 | 17.62 | 25.67 | 31.79 | 26.02 | 31.98 | Upgrade
|
| Other Current Liabilities | 1.98 | 1.74 | 1.29 | 1.27 | 0.67 | 0.79 | Upgrade
|
| Total Current Liabilities | 35.92 | 38.17 | 45.94 | 55.55 | 40.69 | 40.92 | Upgrade
|
| Long-Term Leases | 34.12 | 34.04 | 36.84 | 39.36 | - | 6.93 | Upgrade
|
| Long-Term Unearned Revenue | 37.51 | 44.77 | 66.68 | 92.09 | 114.72 | 120.81 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.01 | Upgrade
|
| Total Liabilities | 107.55 | 116.98 | 149.46 | 186.99 | 155.41 | 168.65 | Upgrade
|
| Common Stock | 0.11 | 0.11 | 0.1 | 0.09 | 0.09 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 707.89 | 700.63 | 624.08 | 522.61 | 506.76 | 141.64 | Upgrade
|
| Retained Earnings | -541.43 | -501.56 | -371.26 | -269.51 | -161.34 | -103.1 | Upgrade
|
| Comprehensive Income & Other | 0.19 | 0.34 | 0.19 | -3.71 | -0.77 | 0.02 | Upgrade
|
| Total Common Equity | 166.76 | 199.52 | 253.11 | 249.48 | 344.75 | 38.6 | Upgrade
|
| Shareholders' Equity | 166.76 | 199.52 | 253.11 | 249.48 | 344.75 | 38.6 | Upgrade
|
| Total Liabilities & Equity | 274.31 | 316.49 | 402.57 | 436.47 | 500.16 | 207.25 | Upgrade
|
| Total Debt | 36.95 | 36.49 | 38.92 | 41.13 | 1.5 | 7.88 | Upgrade
|
| Net Cash (Debt) | 179.78 | 221.42 | 297.97 | 325 | 483.75 | 182.44 | Upgrade
|
| Net Cash Growth | -41.13% | -25.69% | -8.32% | -32.82% | 165.16% | 472.15% | Upgrade
|
| Net Cash Per Share | 1.64 | 2.03 | 3.15 | 3.70 | 7.79 | 5.71 | Upgrade
|
| Filing Date Shares Outstanding | 108.39 | 108.11 | 106.72 | 88.2 | 87.71 | 14.2 | Upgrade
|
| Total Common Shares Outstanding | 107.73 | 107.73 | 102.2 | 88.18 | 87.6 | 13.3 | Upgrade
|
| Working Capital | 189.01 | 228.17 | 300.6 | 319.73 | 451.65 | 152.72 | Upgrade
|
| Book Value Per Share | 1.55 | 1.85 | 2.48 | 2.83 | 3.94 | 2.90 | Upgrade
|
| Tangible Book Value | 166.76 | 199.52 | 253.11 | 249.48 | 344.75 | 38.6 | Upgrade
|
| Tangible Book Value Per Share | 1.55 | 1.85 | 2.48 | 2.83 | 3.94 | 2.90 | Upgrade
|
| Machinery | 13.32 | 13.32 | 12.88 | 11.65 | 6.25 | 5.14 | Upgrade
|
| Construction In Progress | 0.21 | 0.15 | 0.04 | 0.01 | 0.74 | - | Upgrade
|
| Leasehold Improvements | 2.87 | 2.87 | 2.86 | 2.78 | 0.25 | 0.25 | Upgrade
|
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.